Kunze Kyle N, Persaud Steven, Briano Juan, Rodeo Scott A, Warren Russell F, Wickiewicz Thomas L, Williams Riley J
Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, USA.
Institute for Cartilage Repair, Hospital for Special Surgery, New York, New York, USA.
Am J Sports Med. 2025 May;53(6):1515-1523. doi: 10.1177/03635465241260271. Epub 2025 Jan 6.
Failure of primary cartilage restoration procedures of the knee that proceed to necessitating revision cartilage procedures represent a challenging clinical scenario with variable outcomes reported in previous literature.
To perform a systematic review and meta-analysis of clinical outcomes and adverse events after revision cartilage restoration procedures of the knee for failed primary cartilage procedures.
Systematic review and meta-analysis; Level of evidence, 4.
The PubMed, OVID/MEDLINE, and Cochrane databases were queried in August 2023 for trials reporting on the outcomes of revision cartilage restoration procedures of the knee. Information pertaining to rates of failure, reoperations, graft-related complications, and patient-reported outcome measures were extracted. A meta-analysis using inverse-variance proportion models using Freeman-Tukey double-arcsine transformations and DerSimonian-Laird random-effects estimators was constructed to quantitatively describe the cumulative incidence of adverse events.
Sixteen studies (1361 patients; mean age, 35.7 ± 9.3 years) were included. The most frequently performed revision cartilage procedure was autologous chondrocyte implantation (ACI; n = 755 [55.5%]). The overall rate of failure was 25.1% (95% CI, 14.4%-37.3%) at a mean 6.5 years (range, 2-26 years). The majority of studies (n = 9) reported a failure rate exceeding 20%. A significant reduction in failure was observed in favor of the revision osteochondral allograft cohort (19.0% [75/395] vs 35.7% [273/764]; relative risk, 0.63; < .0001) compared with the revision ACI cohort. The pooled all-cause reoperation event rate was 40.8%, which ranged between 18.2% and 71.4% (13 studies). Of these studies, 12 reported reoperation rates exceeding 20%, and 7 reported rates exceeding 40%. The pooled graft-related complication event rate was 27.2%, which ranged between 5.4% and 56.6% (11 studies). Notably, all analyses demonstrated considerable or moderate heterogeneity, potentially influencing the observed variability in pooled effect estimates.
One of every 4 patients may experience a secondary failure after undergoing a revision cartilage procedure. Revision using an osteochondral allograft may confer a meaningful reduction in the risk of failure relative to revision using ACI. High rates of graft-related complications and reoperations are also frequently observed in this population, highlighting the challenge of treating patients with failed primary treatment of chondral or osteochondral defects of the knee.
膝关节初次软骨修复手术失败后需要进行翻修软骨手术,这是一种具有挑战性的临床情况,以往文献报道的结果各不相同。
对膝关节初次软骨手术失败后进行翻修软骨修复手术的临床结果和不良事件进行系统评价和荟萃分析。
系统评价和荟萃分析;证据等级,4级。
于2023年8月检索PubMed、OVID/MEDLINE和Cochrane数据库,查找关于膝关节翻修软骨修复手术结果的试验。提取与失败率、再次手术率、移植物相关并发症以及患者报告的结局指标相关的信息。构建了一个使用Freeman-Tukey双反正弦变换和DerSimonian-Laird随机效应估计器的逆方差比例模型进行荟萃分析,以定量描述不良事件的累积发生率。
纳入16项研究(1361例患者;平均年龄35.7±9.3岁)。最常进行的翻修软骨手术是自体软骨细胞植入术(ACI;n = 755 [55.5%])。平均6.5年(范围2 - 26年)时,总体失败率为25.1%(95%CI,14.4% - 37.3%)。大多数研究(n = 9)报告的失败率超过20%。与翻修ACI队列相比,翻修骨软骨异体移植队列的失败率显著降低(19.0% [75/395] 对35.7% [273/764];相对风险,0.63;P <.0001)。汇总的全因再次手术事件发生率为40.8%,范围在18.2%至71.4%之间(13项研究)。在这些研究中,12项报告的再次手术率超过20%,7项报告的再次手术率超过40%。汇总的移植物相关并发症事件发生率为27.2%,范围在5.4%至56.6%之间(11项研究)。值得注意的是,所有分析均显示出相当大或中等程度的异质性,这可能影响观察到的汇总效应估计值的变异性。
每4名患者中就有1名在接受翻修软骨手术后可能会出现二次失败。与使用ACI进行翻修相比,使用骨软骨异体移植进行翻修可能会显著降低失败风险。在这一人群中还经常观察到高移植物相关并发症和再次手术率,凸显了治疗膝关节软骨或骨软骨缺损初次治疗失败患者的挑战。